Tracking treatment response in newly diagnosed lymphoma
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study follows people with newly diagnosed non-Hodgkin lymphoma to collect information about how they respond to treatment. It aims to improve understanding and care for this type of blood cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 16 years old or older
- You must have been recently diagnosed with non-Hodgkin lymphoma (a type of blood cancer affecting lymph nodes)
- You must have received standard cancer treatment, not just pain relief or supportive care
- You must have at least one tumour that can be measured to track how well the treatment is working
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with Hodgkin or non-Hodgkin lymphoma who need strong treatment to try to cure their cancer. The goal is to learn more about how the disease and its treatment affect patients over time.
This study looks at real-world data from people with non-Hodgkin lymphoma that involves organs or tissues beyond the lymph nodes. It aims to understand how well different treatments work, so your experience can help improve future care.
This trial looks at how people with lymphoma-related hemophagocytic lymphohistiocytosis (HLH) respond to treatment. It aims to better describe expected outcomes and who benefits most, which may help guide future care.
This study follows patients with relapsed or hard-to-treat B-cell lymphoma who are receiving CD19-directed CAR T cell therapy. Researchers collect blood and tissue samples to better understand each patient's unique risk profile, aiming to improve how the treatment is monitored and managed.
This study checks whether measuring a blood test called “circulating tumor DNA” (ctDNA) helps monitor childhood lymphoma during treatment. It’s meant to see if ctDNA tracking can provide useful information alongside standard exams.
This study collects health information from people recently diagnosed with lymphoma to learn more about how the disease progresses and how to improve long-term well-being. It does not test a new treatment but helps researchers better understand what affects survival and quality of life.
Hear when a new Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.